E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation
Zijia Ren(University of Science and Technology of China), Weihua Xiao(University of Science and Technology of China), Wenyao Kang(University of Science and Technology of China), Xiaoyi Yang(Science Applications International Corporation (United States)), Zhigang Tian(University of Science and Technology of China), Bao‐liang Sun(Shandong First Medical University), Lihua Wang(Jiangxi University of Traditional Chinese Medicine), Chaogu Zheng(University of Hong Kong), Jiajia Ma(Xinjiang Medical University), Jie Sun(Second Military Medical University)
Cited by 44
Related Papers
NK cell-based immunotherapy for malignant diseases
|Cellular and Molecular Immunology|2013|626
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation
|Journal of Clinical Investigation|2013|529
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers
|Nucleic Acids Research|2015|386
NK Cell Exhaustion
|Frontiers in Immunology|2017|306